Integrated DNA Technologies purchases Transgenomic’s Surveyor business

Integrated DNA Technologies has announced the acquisition of the Surveyor product line and intellectual property from fellow life science company Transgenomic.

The firm has purchased the enzyme business as part of its efforts to strengthen its standing in the custom nucleic acid synthesis sector. It will now be able to add the Surveyor enzyme and kits to its range of molecular biology product offerings.

As part of the deal, Transgenomic will receive an exclusive license for clinical and diagnostic use of Surveyor products.

The core offering in the purchased portfolio is Surveyor Nuclease, a member of the CEL nuclease family of mismatch-specific nucleases isolated from celery. Meanwhile, the Surveyor Mutation Detection Kits provide a simple and robust method for detecting mutations and polymorphisms in DNA.

Stephen Gunstream, chief commercial officer at Integrated DNA Technologies, said: "These products will be of great benefit to IDT customers … and of particular use to those whose work involves mutation detection or validation of CRISPR/Cas9 genome editing."

The company was founded in 1987 and serves the needs of 80,000 life sciences researchers worldwide.